1. Home
  2. PSEC vs RZLT Comparison

PSEC vs RZLT Comparison

Compare PSEC & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSEC
  • RZLT
  • Stock Information
  • Founded
  • PSEC 2004
  • RZLT 2010
  • Country
  • PSEC United States
  • RZLT United States
  • Employees
  • PSEC N/A
  • RZLT N/A
  • Industry
  • PSEC Finance/Investors Services
  • RZLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • PSEC Finance
  • RZLT Health Care
  • Exchange
  • PSEC Nasdaq
  • RZLT Nasdaq
  • Market Cap
  • PSEC 1.2B
  • RZLT 997.7M
  • IPO Year
  • PSEC 2004
  • RZLT N/A
  • Fundamental
  • Price
  • PSEC $2.88
  • RZLT $10.00
  • Analyst Decision
  • PSEC Sell
  • RZLT Strong Buy
  • Analyst Count
  • PSEC 1
  • RZLT 6
  • Target Price
  • PSEC $2.50
  • RZLT $15.33
  • AVG Volume (30 Days)
  • PSEC 3.8M
  • RZLT 1.5M
  • Earning Date
  • PSEC 11-06-2025
  • RZLT 11-06-2025
  • Dividend Yield
  • PSEC 18.75%
  • RZLT N/A
  • EPS Growth
  • PSEC N/A
  • RZLT N/A
  • EPS
  • PSEC N/A
  • RZLT N/A
  • Revenue
  • PSEC $680,752,000.00
  • RZLT N/A
  • Revenue This Year
  • PSEC N/A
  • RZLT N/A
  • Revenue Next Year
  • PSEC N/A
  • RZLT N/A
  • P/E Ratio
  • PSEC N/A
  • RZLT N/A
  • Revenue Growth
  • PSEC N/A
  • RZLT N/A
  • 52 Week Low
  • PSEC $2.52
  • RZLT $2.22
  • 52 Week High
  • PSEC $4.88
  • RZLT $11.46
  • Technical
  • Relative Strength Index (RSI)
  • PSEC 62.15
  • RZLT 57.68
  • Support Level
  • PSEC $2.52
  • RZLT $8.55
  • Resistance Level
  • PSEC $2.68
  • RZLT $10.03
  • Average True Range (ATR)
  • PSEC 0.08
  • RZLT 0.77
  • MACD
  • PSEC 0.01
  • RZLT 0.05
  • Stochastic Oscillator
  • PSEC 97.37
  • RZLT 48.34

About PSEC Prospect Capital Corporation

Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: